How can the food industry innovate for GLP-1 drug users?
The use of GLP-1 drugs for weight loss has surged. In January, the market value of Novo Nordisk, the Danish pharmaceutical giant behind leading GLP-1 drug brands Wegovy and Ozempic, reached 500 billion USD, after…